C08G79/04

ELASTIC FLAME-RETARDANT POLYMER-ENCAPSULATED ANODE PARTICLES FOR LITHIUM BATTERIES AND METHOD OF MANUFACTURING
20220246937 · 2022-08-04 · ·

A composite particulate for a lithium battery, wherein the composite particulate has a diameter from 10 nm to 50 μm and comprises one or more than one anode active material particles that are dispersed in a high-elasticity polymer matrix or encapsulated by a high-elasticity polymer shell, wherein the high-elasticity polymer matrix or shell has a recoverable elastic tensile strain no less than 5%, when measured without an additive or reinforcement dispersed therein, and a lithium ion conductivity no less than 10.sup.−8 S/cm at room temperature and wherein the high-elasticity polymer comprises a polymer derived from a monomer selected from the group consisting of phosphates, phosphonates, phosphonic acids, phosphorous acid, phosphites, phosphoric acids, combinations thereof, and combination thereof with phosphazenes. These polymers are also highly flame-resistant.

ELASTIC FLAME-RETARDANT POLYMER-ENCAPSULATED ANODE PARTICLES FOR LITHIUM BATTERIES AND METHOD OF MANUFACTURING
20220246937 · 2022-08-04 · ·

A composite particulate for a lithium battery, wherein the composite particulate has a diameter from 10 nm to 50 μm and comprises one or more than one anode active material particles that are dispersed in a high-elasticity polymer matrix or encapsulated by a high-elasticity polymer shell, wherein the high-elasticity polymer matrix or shell has a recoverable elastic tensile strain no less than 5%, when measured without an additive or reinforcement dispersed therein, and a lithium ion conductivity no less than 10.sup.−8 S/cm at room temperature and wherein the high-elasticity polymer comprises a polymer derived from a monomer selected from the group consisting of phosphates, phosphonates, phosphonic acids, phosphorous acid, phosphites, phosphoric acids, combinations thereof, and combination thereof with phosphazenes. These polymers are also highly flame-resistant.

Polymer electrolyte material for lithium battery cells
11289736 · 2022-03-29 · ·

Lithium battery electrolyte materials comprising fluorinated phosphonates and having a polymer structure defined by: ##STR00001##
where R.sup.1 is —CF.sub.3, —(CF.sub.2).sub.nCF.sub.3 and n is an integer ranging from 1 to 10, perfluoropolyether (PFPE), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), ethylene fluorinated ethylene propylene (EFEP), or polyethylene tetrafluoroethylene (ETFE) and R.sup.2 is —(CF.sub.2).sub.n and n is an integer ranging from 1 to 10, perfluoropolyether (PFPE), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), ethylene fluorinated ethylene propylene (EFEP), or polyethylene tetrafluoroethylene (ETFE).

Polymer electrolyte material for lithium battery cells
11289736 · 2022-03-29 · ·

Lithium battery electrolyte materials comprising fluorinated phosphonates and having a polymer structure defined by: ##STR00001##
where R.sup.1 is —CF.sub.3, —(CF.sub.2).sub.nCF.sub.3 and n is an integer ranging from 1 to 10, perfluoropolyether (PFPE), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), ethylene fluorinated ethylene propylene (EFEP), or polyethylene tetrafluoroethylene (ETFE) and R.sup.2 is —(CF.sub.2).sub.n and n is an integer ranging from 1 to 10, perfluoropolyether (PFPE), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), ethylene fluorinated ethylene propylene (EFEP), or polyethylene tetrafluoroethylene (ETFE).

METHODS FOR THE CONTINUOUS POLYMERIZATION OF PHOSPHATE COMPOUNDS TO FORM POLYPHOSPHATE COMPOSITIONS

Polyphosphate compositions are produced by a process that includes the steps of continuously introducing a phosphate compound into a polymerization vessel, polymerizing the phosphate compound at a temperature of 250-450° C. for a time period sufficient to form the polyphosphate composition, and continuously discharging the polyphosphate composition from the polymerization vessel. The phosphate compound can be fed to the polymerization vessel in the form of an aqueous slurry containing 5-50 wt. % of the phosphate compound. Resulting polyphosphate compositions often contain at least 8 wt. % of a polyphosphate and less than 35 wt. % of the phosphate compound.

METHODS FOR THE CONTINUOUS POLYMERIZATION OF PHOSPHATE COMPOUNDS TO FORM POLYPHOSPHATE COMPOSITIONS

Polyphosphate compositions are produced by a process that includes the steps of continuously introducing a phosphate compound into a polymerization vessel, polymerizing the phosphate compound at a temperature of 250-450° C. for a time period sufficient to form the polyphosphate composition, and continuously discharging the polyphosphate composition from the polymerization vessel. The phosphate compound can be fed to the polymerization vessel in the form of an aqueous slurry containing 5-50 wt. % of the phosphate compound. Resulting polyphosphate compositions often contain at least 8 wt. % of a polyphosphate and less than 35 wt. % of the phosphate compound.

Optimized Stent Jacket with Large Apertures
20210322187 · 2021-10-21 ·

An intravascular device configured to treat an aneurysm that includes a support structure including metal struts configured to be positioned in a body lumen and defining a central fluid passage that extends axially along the support structure, and a knitted mesh cover disposed over an exterior thereof and across a radial arc and along a length of the support structure sufficient to exceed an opening of an aneurysm to be treated, and the cover includes a polymer fiber having a diameter of at least 40 nanometers to 30 microns and apertures therethrough, the apertures being sized to prevent blood from passing through the device to prevent further expansion of the aneurysm. Devices including apertures that are at least 20 microns and sized to minimize or prevent an aneurysm-filling material from exiting the aneurysm through the knitted mesh cover and support structure, and methods of stenting, are also encompassed.

Optimized Stent Jacket with Large Apertures
20210322187 · 2021-10-21 ·

An intravascular device configured to treat an aneurysm that includes a support structure including metal struts configured to be positioned in a body lumen and defining a central fluid passage that extends axially along the support structure, and a knitted mesh cover disposed over an exterior thereof and across a radial arc and along a length of the support structure sufficient to exceed an opening of an aneurysm to be treated, and the cover includes a polymer fiber having a diameter of at least 40 nanometers to 30 microns and apertures therethrough, the apertures being sized to prevent blood from passing through the device to prevent further expansion of the aneurysm. Devices including apertures that are at least 20 microns and sized to minimize or prevent an aneurysm-filling material from exiting the aneurysm through the knitted mesh cover and support structure, and methods of stenting, are also encompassed.

POLYIMIDE COMPOSITE MATERIAL, MANUFACTURING METHOD THEREOF, AND DISPLAY SUBSTRATE
20210324143 · 2021-10-21 ·

A polyimide composite material, a manufacturing method thereof, and a display substrate are provided. Inorganic nanoparticles are connected with polyimide structural units by chemical bonds, thus enhancing compatibility of the inorganic nanoparticles and the polyimide structural units. Moreover, because of an enhancement effect of the inorganic nanoparticles, a mechanical property and thermal stability of the polyimide composite material may be effectively improved.

Compositions with permeation enhancers for drug delivery

The present invention provides compositions and methods for delivery of therapeutic agents across an barrier. The compositions include a therapeutic agent (e.g., antimicrobial agent, antibiotic, or anesthetic agent), a permeation enhancer which increases the flux of the therapeutic agent across the barrier, and a matrix forming agent. The matrix forming agent forms a gel at a suitable gelation temperature and rheological properties for use in drug delivery, and in some cases, the gelation temperature and rheological properties are not significantly changed from those of the composition without the permeation enhancer. The invention also provides a matrix forming agent and compositions thereof. Such compositions are particularly useful in the treatment of otitis media. Methods of treatment, methods of delivery, and kits for the compositions described herein are also provided.